Characterisation of radicals formed by the triazine 1,4-dioxide hypoxia-activated prodrug, SN30000.
about
Quinoxaline 1,4-di-N-Oxides: Biological Activities and Mechanisms of ActionsTargeting the hypoxic fraction of tumours using hypoxia-activated prodrugsReductive Metabolism Influences the Toxicity and Pharmacokinetics of the Hypoxia-Targeted Benzotriazine Di-Oxide Anticancer Agent SN30000 in Mice.Application of Suzuki-Miyaura and Buchwald-Hartwig Cross-coupling Reactions to the Preparation of Substituted 1,2,4-Benzotriazine 1-Oxides Related to the Antitumor Agent Tirapazamine.Bystander Effects of Hypoxia-Activated Prodrugs: Agent-Based Modeling Using Three Dimensional Cell Cultures
P2860
Characterisation of radicals formed by the triazine 1,4-dioxide hypoxia-activated prodrug, SN30000.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh-hant
name
Characterisation of radicals f ...... ia-activated prodrug, SN30000.
@en
Characterisation of radicals f ...... ia-activated prodrug, SN30000.
@nl
type
label
Characterisation of radicals f ...... ia-activated prodrug, SN30000.
@en
Characterisation of radicals f ...... ia-activated prodrug, SN30000.
@nl
prefLabel
Characterisation of radicals f ...... ia-activated prodrug, SN30000.
@en
Characterisation of radicals f ...... ia-activated prodrug, SN30000.
@nl
P2093
P2860
P50
P356
P1476
Characterisation of radicals f ...... ia-activated prodrug, SN30000.
@en
P2093
Andrej Maroz
Jóhannes Reynisson
Pooja Yadav
Robert F Anderson
Smitha R Tipparaju
Sujata S Shinde
William A Denny
P2860
P304
P356
10.1039/C4OB00236A
P577
2014-04-16T00:00:00Z